TABLE 2.
Mo-Ly6ChiTLR2hi (X N) | Mo-Ly6CloTLR2hi (X n) | |
---|---|---|
WT NI | 1.00 ± 0.13 | 1.0 ± 0.9 |
WT I | 1.18 ± 0.04a | 10.0 ± 0.4b |
TLR2−/− Ic | 0.59 ± 0.14d | 11.0 ± 0.8 |
TLR9−/− I | 0.70 ± 0.06d | 11.0 ± 1.2 |
IL-12−/− I | 1.00 ± 0.18 | 5.1 ± 1.1e |
Mal/TIRAP−/− I | 0.41 ± 0.03e | 7.2 ± 0.2d |
a p < 0.05 compared with WT, non-infected cells.
b p < 0.001 compared with WT, non-infected cells.
c Cells from TLR2−/− mice were evaluated only by the interpolation (CD11c versus Ly6C).
d p < 0.01 compared with WT, infected cells (bold type).
e p < 0.001 compared with WT, infected cells (bold type) by the ANOVA and Bonferroni post-tests.